Le Lézard
Classified in: Health, Science and technology, Business
Subjects: SVY, LIC

Backpack Health Launches Rare Disease Research Study in Partnership with Project Alive


DOVER, Mass., Nov. 19, 2019 /PRNewswire/ -- Backpack Health, a free mobile and web-based multilingual digital platform giving consumers control of their health data with continuous and sharable access to their full medical record, today announced that it has launched a research study together with Project Alive to further medical research and understanding of Hunter syndrome. Using patient-reported data from Backpack Health's Hunter Syndrome International Patient Registry, Project Alive will examine potential associations between approved and experimental therapies and toileting skills among patients with neurocognitive and attenuated forms of Hunter syndrome.

"Our focus on patient empowerment recognizes that patients and caregivers often identify the impact of a rare disease early, even before the clinician or care team," said Jim Cavan, founder and CEO of Backpack Health. "Our partnership with Project Alive is also a collaboration with Backpack Health users in the Hunter syndrome community who are motivated to share de-identified data for the sake of medical research. We are thrilled to see the high enrollment rate from our users since we kicked off this initiative and feel encouraged by the support and enthusiasm of this community to build a brighter future."

Hunter syndrome, also known as MPS II, is a genetic metabolic condition or lysosomal storage disorder that affects one in 100,000 to one in 170,000 individuals and is almost exclusively found in males. Individuals affected with a severe form of the condition begin to lose basic functional skills between the ages of two and four and have a shortened life expectancy.

"In the rare disease community, we often have to wait until researchers come to us with a possible treatment," said Kim Stephens, President of Project Alive. "In this partnership with Backpack Health, the Hunter syndrome community is being more proactive and actively helping researchers collect meaningful data and find a cure."

Backpack Health's customized health data management platform for Hunter syndrome helps users control their health journey with a secure centralized location for tracking, storing and sharing health information. Backpack Health users who are part of the Hunter syndrome community can now opt-in to participate in quarterly surveys. The next survey will launch on November 19, 2019.

"Giving patients more control over their own health data will change the way we approach research studies," said Christian Hendriksz, M.D., advisor to Project Alive, Professor of Pediatrics and Child Health at the University of Pretoria with involvement in multiple clinical trials for MPS II. "With more patients enrolled in a registry, we can begin making connections and uncover insights that may have previously gone unnoticed."

About Backpack Health

Backpack Health, LLC builds secure, innovative information tools to help people manage their health journey ? including wellness, illnesses, injuries, and chronic health conditions, reaching users in 100 countries around the world. The Backpack Health mission is to make it easy for everyone to access, own and control their health information to support better health care and attain better health for themselves, their loved ones and their communities. Backpack Health provides a platform for organizations to engage patients, collect up-to-date data and build communities around the globe. To assure data protection for its users' information, Backpack Health complies with the EU General Data Protection Regulation (GDPR), adheres to its data protection principles, participates in the EU-U.S. and Swiss-U.S. Privacy Shield Frameworks and does not share any user data with third parties, including social media companies. Learn more at www.backpackhealth.com.

About Project Alive 

Project Alive is a non-profit organization dedicated to finding a cure for Hunter syndrome (Mucopolysaccharidosis II) through research and advocacy. It is a powerful voice for children and adults with Hunter syndrome, bringing together families and advocates with researchers, industry, and regulators. Project Alive funds promising curative research, assists researchers and industry with designing research studies for our community, and advocates for the most effective and efficient system of clinical research, evaluation, and approval. Through its innovative campaigns and grassroots efforts, Project Alive has made significant advances in public awareness about Hunter syndrome and its symptoms, the need for early diagnosis, and available treatments and clinical trials. 

Media Relations Contact for Backpack Health
Nechama Feuerstein
Finn Partners
+1-646-213-7246  
Nechama.feurestein@finnpartners.com

Media Relations Contact for Project Alive
Barbara Esteves-Moore 
Project Alive 
+1-615-631-4383 
Bem@tworoadscommunications.com 

SOURCE Backpack Health


These press releases may also interest you

at 03:00
Dr. Scott Howell, a 2019 graduate of Trident University International's (Trident) Ph.D. in Health Sciences program, recently published research on the health benefits of coconut oil in the 7 November 2019 edition of Progress in Cardiovascular...

at 02:08
Biovica, active in cancer diagnostics, today announced that Henrik Winther was appointed SVP Business Development and will be part of the management team. He most recently comes from the role of SVP Precision Diagnostics at Immunovia. "Henrik...

at 02:00
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Life & Brain Genomics, a division of Life & Brain GmbH. Life & Brain Genomics is one of the leading European service...

at 01:05
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following discussions with the U.S. Food and Drug Administration (FDA), that a partial clinical hold effective immediately, for the pediatric population under the age of 14 was...

5 déc 2019
Health Canada is aware that some metformin products available outside Canada have been found to contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), above the acceptable limit. Metformin is a prescription drug used to control high blood...

5 déc 2019
A recent incident at Sunrise Community Health ("Sunrise") may affect the privacy of certain information. Sunrise is unaware of any actual or attempted misuse of this information. However, Sunrise is providing notification to individuals whose...



News published on 19 november 2019 at 08:00 and distributed by: